Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
252.00
Ask:
257.00
Spread: 5.00 (1.984%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

SAYE and Director/PDMR Shareholding

1 Apr 2019 07:00

RNS Number : 5280U
Wilmington PLC
01 April 2019
 

1 April 2019

Wilmington plc

("Wilmington" or the "Company" or "Group")

SAYE and Director/PDMR Shareholding

 

On 29 March 2019, Save As You Earn Options ('SAYE Options') with a per share exercise price of £1.52 over 688,612 ordinary shares in Wilmington plc (the "Company") were granted under the Wilmington SAYE Plan 2018 (the "SAYE Scheme") to employees of the Company and its subsidiaries. Participation in the SAYE Scheme was open to all eligible employees as defined by the scheme. The exercise price of £1.52 was calculated in accordance with the rules as set out in the SAYE Scheme. The SAYE Options will normally vest and become exercisable over a three year vesting period from the date of grant and can be exercised within six months following vesting.

 

SAYE Options were made to certain Directors of the Company and other Persons Discharging Managerial Responsibilities ("PDMRs"):

 

Name of Director/PDMR

Number of shares subject to award

Richard Amos (Executive Director)

7,105

Thomas Mount (PDMR)

7,105

Tony Bainbridge (PDMR)

7,105

 

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

 

 

For further information, please contact:

Wilmington plc

Daniel Barton, Company Secretary

 

 

020 7490 0049

 

 

Notes to Editors

 

Wilmington is the recognised knowledge leader and partner of choice for information, education and networking in Risk & Compliance, Professional and Healthcare areas. Wilmington employs close to 1,000 people and operates in 120 countries. Wilmington plc is a premium listed company on the main market of the London Stock Exchange.

 

 

 

 

 

Notification of Dealing Form

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Richard Amos

2.

Reason for the notification

a)

Position/status

Executive Director

b)

Initial notification/amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Wilmington plc

b)

LEI code

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary Shares in Wilmington plc

ISIN: GB0009692319

b)

Nature of the transaction

Grant of SAYE Option over Ordinary Shares under the Company's SAYE Plan 2018

c)

Price(s) and volumes(s)

Price

Volume

152 pence

7,105

 

d)

Aggregated information

- Aggregate volume

- Price

N/A

e)

Date of the transaction

29 March 2019

f)

Place of the transaction

Outside a trading venue

 

 

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Thomas Mount

2.

Reason for the notification

a)

Position/status

PDMR

b)

Initial notification/amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Wilmington plc

b)

LEI code

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary Shares in Wilmington plc

ISIN: GB0009692319

b)

Nature of the transaction

Grant of SAYE Option over Ordinary Shares under the Company's SAYE Plan 2018

c)

Price(s) and volumes(s)

Price

Volume

152 pence

7,105

 

d)

Aggregated information

- Aggregate volume

- Price

N/A

e)

Date of the transaction

29 March 2019

f)

Place of the transaction

Outside a trading venue

 

 

 

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Tony Bainbridge

2.

Reason for the notification

a)

Position/status

PDMR

b)

Initial notification/amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Wilmington plc

b)

LEI code

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary Shares in Wilmington plc

ISIN: GB0009692319

b)

Nature of the transaction

Grant of SAYE Option over Ordinary Shares under the Company's SAYE Plan 2018

c)

Price(s) and volumes(s)

Price

Volume

152 pence

7,105

 

d)

Aggregated information

- Aggregate volume

- Price

N/A

e)

Date of the transaction

29 March 2019

f)

Place of the transaction

Outside a trading venue

 

 

 

-End-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEADDNADLNEFF
Date   Source Headline
17th Apr 202611:20 amRNSHolding(s) in Company
15th Apr 20263:56 pmRNSBoard changes
15th Apr 202611:21 amRNSSave As You Earn Options
11th Mar 202611:00 amRNSDirector Declaration
11th Mar 202611:00 amRNSDirector Declaration
26th Feb 20267:00 amRNSHalf-year Financial Report
11th Feb 20262:44 pmRNSNotice of half year-end results
21st Jan 202611:19 amRNSNotice of Half Year Results
23rd Dec 20257:00 amRNSAppointment of Joint Corporate Broker
23rd Dec 20257:00 amRNSAppointment of Joint Corporate Broker
5th Dec 20259:56 amRNSAcquisition of Conversia completed
28th Nov 20254:23 pmRNSDirector/PDMR Shareholding
28th Nov 202511:22 amRNSAcquisition of Conversia cleared to complete
25th Nov 20259:19 amRNSResult of AGM
10th Nov 20255:54 pmRNSDirectorate change
1st Oct 20252:51 pmRNSDirector/PDMR Shareholding
1st Oct 20252:49 pmRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSTotal Voting Rights
22nd Sep 202512:48 pmRNSDirector/PDMR Shareholding- Replacement
22nd Sep 202511:52 amRNSDirector/PDMR Shareholding
22nd Sep 20257:00 amRNSFinancial results for the year ended 30 June 2025
5th Sep 202510:58 amRNSHolding(s) in Company
1st Sep 20257:00 amRNSNotice of year-end results
29th Aug 202511:07 amRNSHolding(s) in Company
12th Aug 20257:03 amRNSProposed acquisition of Conversia
12th Aug 20257:00 amRNSDirector Declaration
1st Aug 20257:00 amRNSAppointment of Joint Corporate Broker
30th Jul 20257:00 amRNSStatement in relation to a potential acquisition
23rd Jul 20257:00 amRNSTrading Statement
1st Jul 20257:00 amRNSTotal Voting Rights
26th Jun 20259:00 amRNSDirector/PDMR Shareholding
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20259:30 amRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.